Related references
Note: Only part of the references are listed.Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes
T. Heise et al.
DIABETES OBESITY & METABOLISM (2013)
Comment on: Turban et al. Optimal Elevation of -Cell 11 -Hydroxysteroid Dehydrogenase Type 1 Is a Compensatory Mechanism That Prevents High-Fat Diet-Induced -Cell Failure. Diabetes 2012;61:642-652
J.-L. Liu et al.
DIABETES (2012)
Association Between Glycosylated Hemoglobin and Intentional Weight Loss in Overweight and Obese Patients With Type 2 Diabetes Mellitus A Retrospective Cohort Study
Ghanshyam Palamaner Subash Shantha et al.
DIABETES EDUCATOR (2012)
The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia
R. A. DeFronzo et al.
DIABETES OBESITY & METABOLISM (2012)
Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
R. Grempler et al.
DIABETES OBESITY & METABOLISM (2012)
Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs
C. Ll. Morgan et al.
DIABETES OBESITY & METABOLISM (2012)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi et al.
DIABETOLOGIA (2012)
Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD)
Ishan Hirji et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2012)
Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II)
Jan Cederholm et al.
JOURNAL OF HYPERTENSION (2012)
Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
Rena R. Wing et al.
DIABETES CARE (2011)
THE PARATHYROID GLANDS: WHAT THE ENDOCRINE SURGEON SHOULD KNOW Indian Rhino Club
Nancy D. Perrier
ENDOCRINE PRACTICE (2011)
Glucose handling by the kidney
Amanda Mather et al.
KIDNEY INTERNATIONAL (2011)
Renal glucose reabsorption inhibitors to treat diabetes
Clifford J. Bailey
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life
Michael F. Pollack et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
Olivia J. Phung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Sulphonyurea as a cause of severe hypoglycaemia in the community
Jen M. Ng et al.
PRIMARY CARE DIABETES (2010)
Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents
A. B. Hauber et al.
DIABETIC MEDICINE (2009)
Weight Change in Diabetes and Glycemic and Blood Pressure Control
Adrianne C. Feldstein et al.
DIABETES CARE (2008)
Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia A nested case-control analysis
Michael Bodmer et al.
DIABETES CARE (2008)
Uric acid and cardiovascular risk
Daniel I. Feig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pregnancy outcomes following hospitalization for motor vehicle crashes in Washington State from 1989 to 2001
MA Schiff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men -: A prospective cohort study
LK Niskanen et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Defining the relationship between plasma glucose and HbA1c -: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial
CL Rohlfing et al.
DIABETES CARE (2002)
Share Paper
